Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2019-04-18 History
Report ID 64245
Drug Identification Number 02398427
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 2MLx1 VIAL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-28
Estimated end date 2020-04-06
Actual end date
Shortage status Actual shortage
Updated date 2019-04-18
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-04-18 French Compare
v9 2019-04-18 English Compare
v8 2019-04-15 French Compare
v7 2019-04-15 English Compare
v6 2019-01-16 French Compare
v5 2019-01-16 English Compare
v4 2018-12-13 French Compare
v3 2018-12-13 English Compare
v2 2018-10-15 French Compare
v1 2018-10-15 English Compare